Medplus Health Services · NSE: MEDPLUS · BSE: 543427
Q4 FY25 results · Jan–Mar 2025
Medplus Health Services reported revenue from operations of ₹1,509.61 crore (up 1.3% from Q4 FY24) and net profit of ₹51.32 crore (up 52.9% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,509.61 | 1,490.50 | +1.3% | 1,561.45 | −3.3% |
| Other income | 15.79 | 10.46 | +51.0% | 12.52 | +26.2% |
| Total income | 1,525.40 | 1,500.96 | +1.6% | 1,573.96 | −3.1% |
| Profit before tax | 61.12 | 31.98 | +91.1% | 56.60 | +8.0% |
| Net profit for the period | 51.32 | 33.56 | +52.9% | 45.87 | +11.9% |
| Attributable to shareholders of the company | 51.34 | 33.40 | +53.7% | 45.89 | +11.9% |
| EPS, basic (₹) | 4.32 | 2.81 | +53.7% | 3.84 | +12.5% |
| Net margin (%) | 3.4 | 2.3 | 2.9 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 201.75 | 148.37 | +36.0% | 176.79 | +14.1% |
| Other income | 2.65 | 1.90 | +39.7% | 2.19 | +21.1% |
| Total income | 204.40 | 150.27 | +36.0% | 178.98 | +14.2% |
| Profit before tax | 17.91 | 6.32 | +183.3% | 12.03 | +48.9% |
| Net profit for the period | 13.98 | 9.92 | +41.0% | 9.37 | +49.2% |
| EPS, basic (₹) | 1.17 | 0.83 | +41.0% | 0.78 | +50.0% |
| Net margin (%) | 6.9 | 6.7 | 5.3 |
Consolidated
- Filed with BSE
- 07 Nov 2025, 18:12 IST
- Board meeting
- 27 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Nov 2025, 18:12 IST
- Board meeting
- 27 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Audited
- Source
- XBRL filing on BSE